Inhibitors of endocannabinoid degradation: potential therapeutics for neurological disorders.
Wendeler
Michaela
M
Kekulé-Institut für Organische Chemie und Biochemie, Universität Bonn, Gerhard-Domagk Strasse 1, 53121 Bonn, Germany.
Kolter
Thomas
T
D000581:Amidohydrolases / Q000037:antagonists & inhibitors / Q000378:metabolism; D063387:Cannabinoid Receptor Antagonists; D063385:Cannabinoid Receptor Modulators / Q000378:metabolism*; D002186:Cannabinoids / Q000037:antagonists & inhibitors / Q000378:metabolism; D015195:Drug Design; D063388:Endocannabinoids; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D008024:Ligands; D009422:Nervous System Diseases / Q000188:drug therapy; D043882:Receptors, Cannabinoid / Q000378:metabolism; D000099252:Fatty Acid Amide Hydrolases
D000581:Amidohydrolases; D063387:Cannabinoid Receptor Antagonists; D063385:Cannabinoid Receptor Modulators; D002186:Cannabinoids; D063388:Endocannabinoids; D004791:Enzyme Inhibitors; D008024:Ligands; D043882:Receptors, Cannabinoid; D000099252:Fatty Acid Amide Hydrolases